Pricing Log in Create free account
Friday 6 November 2026 Export REGN’s income statement to Excel — free account

Regeneron Pharmaceuticals, Inc.

REGN Healthcare Biotechnology

Regeneron Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, up 0.99% from fiscal 2024.

Revenue
+36.3%
EPS
+36.0%
Free cash flow
+3.85%
Total debt
−26.6%

Quarter to September 2026, against a year earlier

909.45 6.55 +0.73%
Market cap
$93.4B
P/E
19.2×
Fwd P/E
19.2×
Dividend yield
0.41%
F-score
5/9
Altman Z
7.49
Beneish M
−2.53
Dividend safety
77/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Regeneron Pharmaceuticals, Inc. (REGN) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Regeneron Pharmaceuticals, Inc. (REGN) trades at a EV/FCF of 23.7×. Over the past ten years it has ranged from −1,854× (August 2015) to 255× (June 2015); the current reading is higher than 45% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 20.3× 0.15%
FY2024 20.2× (17.43%)
FY2023 24.5× 13.16%
FY2022 21.7× 119.20%
FY2021 9.9× (62.35%)
FY2020 26.2× 36.38%
FY2019 19.2× (8.70%)
FY2018 21.1× (45.43%)
FY2017 38.6× (3.69%)
FY2016 40.1× (52.62%)

Quarterly newest first

Period EV/FCF Change
Sep 2026 19.7× 17.91%
Jun 2026 16.7× (15.85%)
Mar 2026 19.8× (2.31%)
Dec 2025 20.3× 45.68%
43 more quarters

Against its own ten years

Low −1,854× High 255×
Ten-year median 24.9×
Current reading's percentile 47

EV/FCF against peers

Company EV/FCF
MRNA Moderna, Inc. compare −73.7×
ROIV Roivant Sciences Ltd. compare −28.1×
RVMD Revolution Medicines, Inc. compare −25.0×
GMAB Genmab A/S Sponsored ADR compare −5.7×
REGN Regeneron Pharmaceuticals, Inc. 23.7×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 27.1×
RPRX Royalty Pharma PLC compare 29.5×
ARGX argenex SE compare 38.4×
VRTX Vertex Pharmaceuticals Incorporated compare 42.1×

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on REGN